Kala Bio, Inc. · NASDAQ:KALA
Kala Bio, Inc. shareholders
As of Jun 30, 2026, 12 institutions reported holding Kala Bio, Inc., 3.2% of its shares. Largest: Vanguard, Geode Capital and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kala Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 322K | 1.7% | +232K | Aug 13, 2026 |
| Geode Capital | 145K | 0.75% | −116K | Aug 12, 2026 |
| BlackRock | 71,542 | 0.37% | +60,733 | Aug 7, 2026 |
| Northern Trust | 41,606 | 0.22% | +30,082 | Aug 13, 2026 |
| Qube Research & Technologies Ltd | 11,073 | 0.06% | new | Aug 14, 2026 |
| Goldman Sachs | 10,921 | 0.06% | −3,127 | Aug 14, 2026 |
| UBS | 9,057 | 0.05% | −57,814 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 616 | <0.01% | new | Aug 11, 2026 |
| Barclays | 608 | <0.01% | new | Aug 14, 2026 |
| Morgan Stanley | 28 | <0.01% | −2,913 | Aug 13, 2026 |